Tetraphase Pharmaceu (TTPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -66,742 | -29,636 | -15,087 | -21,564 |
| Depreciation Amortization | 350 | 471 | 528 | 599 |
| Accounts receivable | -1,752 | 746 | -2,267 | -185 |
| Accounts payable and accrued liabilities | 2,224 | 310 | 772 | -305 |
| Other Working Capital | 3,422 | 3,422 | -2,901 | 798 |
| Other Operating Activity | 4,875 | 181 | 2,298 | 781 |
| Operating Cash Flow | $-57,623 | $-24,506 | $-16,657 | $-19,876 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -191 | -129 | -54 | -65 |
| Investing Cash Flow | $-191 | $-129 | $-54 | $-65 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | N/A | 3,000 | 6,200 | 8,000 |
| Debt Repayment | -6,126 | -4,232 | -2,197 | -52 |
| Common Stock Issued | 82,270 | 119,500 | -582 | 32 |
| Other Financing Activity | 0 | 0 | -85 | -170 |
| Financing Cash Flow | $76,144 | $118,268 | $3,336 | $7,810 |
| Beginning Cash Position | 102,712 | 9,079 | 22,454 | 34,585 |
| End Cash Position | 121,042 | 102,712 | 9,079 | 22,454 |
| Net Cash Flow | $18,330 | $93,633 | $-13,375 | $-12,131 |
| Free Cash Flow | ||||
| Operating Cash Flow | -57,623 | -24,506 | -16,657 | -19,876 |
| Capital Expenditure | -191 | -129 | -54 | -65 |
| Free Cash Flow | -57,814 | -24,635 | -16,711 | -19,941 |